EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H25N3O4 |
| Net Charge | 0 |
| Average Mass | 359.426 |
| Monoisotopic Mass | 359.18451 |
| SMILES | CCc1ccc(OCCCNC(C)=C2C(=O)N(C)C(=O)N(C)C2=O)cc1 |
| InChI | InChI=1S/C19H25N3O4/c1-5-14-7-9-15(10-8-14)26-12-6-11-20-13(2)16-17(23)21(3)19(25)22(4)18(16)24/h7-10,20H,5-6,11-12H2,1-4H3 |
| InChIKey | ZGCQRYAOMLBSQR-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 5-[1-[3-(4-ethylphenoxy)propylamino]ethylidene]-1,3-dimethyl-1,3-diazinane-2,4,6-trione (CHEBI:115001) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-26463 | LINCS |